Review Article
Intestinal Dysbiosis and Rheumatoid Arthritis: A Link between Gut Microbiota and the Pathogenesis of Rheumatoid Arthritis
Table 3
Summary of studies evaluating the effect of probiotics on the level of rheumatoid arthritis activity.
| Author (year of publication) | Design | Population and intervention | Outcomes |
| Hatakka et al. [89] | Clinical trial | Lactobacillus group (). Placebo group () | There were no statistically significant differences in: CRP, ESR, IL-6, IL-10, IL-12, and HAQ | Pineda et al. [86] | Clinical trial | 15 subjects Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 administered for 3 months versus 14 subjects in the control group | Probiotics did not statistically improve the percentage of ACR 20 response (20% versus 7%, ) | Alipour et al. [84] | Clinical trial | 22 subjects with Lactobacillus casei versus 24 subjects with placebo | Statistically significant decrease in CRP level, count of inflamed and painful joints and in DAS-28 | Vaghef-Mehrabany et al. [85] | Clinical trial | 22 subjects with Lactobacillus casei versus 24 subjects with placebo (maltodextrin) | Statistically significant decrease in level of TNF-α, IL-6, and IL-12 count of inflamed and painful joints and in DAS-28 |
|
|
CRP: C-reactive protein; DAS28: disease activity score-28; IL: interleukin; ESR: erythrocyte sedimentation rate; ACR: American College of Rheumatology.
|